KCT0003144
Recruiting
未知
The clinical performance of imaging and biomarker assessments for non-alcoholic fatty liver disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Endocrine, nutritional and metabolic disease
- Sponsor
- Gachon University Gil Medical Center
- Enrollment
- 75
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •.\-Subjects who provided written informed consent
- •\-Aged 19\-70 years
- •\-those suspected of having NAFLD and belong to one of the followings: who planned to receive liver biopsy or who received liver biopsy for NAFLD within the past 3 months, NAFLD fibrosis score \> 0\.675, or liver stiffness on FibroScan \> 7\.5 kPa
- •\-no congenital or systemic illnesses requiring specific treatment except for NAFLD
- •\-Those seemed appropriate for study participation on screening tests involving medical history, physical examinations, blood cell test, serum/plasma biochemistry, and urine analysis
- •\-Healthy adult subjects aged between 19 and 70 years as normal control subjects
Exclusion Criteria
- •\-Aged less than 19 years or more than 70 years
- •\-Pregnancy
- •\-Drug abusers
- •\-Alcohol drink \> 30 g/day (about 3 unit/day) in male and \> 20 g/day (about 2 unit/day) in female during the last 5 years
- •\-Contraindications to MRI examination
- •\-Other liver diseases except for NAFLD
- •\-Liver cirrhosis with ascites or biliary tract diseases
- •\-Medications causing fatty liver (e.g., corticosteroids, tamoxifen, amiodarone, methotrexate and others)
- •\-Other systemic diseases seemed to be inappropriate for study participation
- •\-Inappropriate for study participation at the discretion of attending physicians
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evaluation of imaging biomarkers and longitudinal assessment of global and regional cardiac function by cardiac MRI during recovery from COVID-19 infection in a multicenter normalized cohortZ03.8Observation for other suspected diseases and conditionsDRKS00028901Klinikum der Universität München, Campus Großhadern150
Recruiting
Not Applicable
Prognostic value of imaging biomarkers in patients with hepatocellular carcinoma treated with liver TransplantatioC22.0Liver cell carcinomaDRKS00027969MU München200
Recruiting
Not Applicable
A non-randomised study investigating the use and timing of multiparametric magnetic resonance imaging (mpMRI) and positron emission tomography (PET) to develop imaging biomarkers that will be used to predict treatment response following radiotherapy for prostate cancer treatment.ACTRN12618001810202niversity of Sydney30
Recruiting
Not Applicable
Analysis of imaging biomarkers in development and growth of geographic atrophy in Japanese with dry aged macular degeneratiodry age-related macular degenerationJPRN-UMIN000050605Jichi Medical University40
Recruiting
Not Applicable
Clinical evaluation of the usefulness of image-enhanced endoscopy for detection of gastrointestinal tumorsesophageal and gastric tumorsJPRN-UMIN000011139Departments of Gastroenterology, The University of Tokyo400